Peroxisome proliferator-activated receptor gamma polymorphism is related to peak bone mass: The JPOS study

Osteoporosis International

Volumn 21, Issue 2, 2010, Pages 321-329

  Tamaki, J ^a   Iki, M ^a   Morita, A ^b   Ikeda, Y ^c   Sato, Y ^d   Kajita, E ^e   Kagamimori, S ^f   Kagawa, Y ^g   Yoneshima, H ^h  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c KINDAI UNIVERSITY HOSPITAL   (Japan)

^d JIN AI UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

^g KAGAWA NUTRITION UNIVERSITY   (Japan)

^h Shuuwa General Hospital   (Japan)

Author keywords

Bone mineral density; Cohort study; Polymorphism; PPAR ; Women

Indexed keywords

CYSTEINE; GENOMIC DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THREONINE;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; DNA POLYMORPHISM; FEMALE; FEMUR FRACTURE; FEMUR NECK; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HIP FRACTURE; HUMAN; HUMAN CELL; JAPANESE; MENSTRUATION; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; EPIDEMIOLOGIC METHODS; FEMALE; FEMUR NECK; GENOTYPE; HIP JOINT; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PPAR GAMMA; PREMENOPAUSE; YOUNG ADULT;

EID: 76549116464     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0965-3     Document Type: Article

References (29)

1. NA Pocock JA Eisman JL Hopper, et al. 1987 Genetic determinants of bone mass in adults. A twin study J Clin Invest 1987 80 706 710 10.1172/JCI113125
2. QY Huang GH Li WM Cheung, et al. 2007 Prediction of osteoporosis candidate genes by computational disease-gene identification strategy J Hum Genet 53 644 655 10.1007/s10038-008-0295-x
3. ME Greene B Blumberg OW McBride, et al. 1995 Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expr 4 281 299 1:CAS:528:DyaK2MXlt1ensbc%3D 7787419
4. WA Hsueh R Law 2003 The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease Am J Cardiol 92 3J 9J 10.1016/S0002-9149(03)00610-6 1:CAS:528:DC%2BD3sXnvVSht7s%3D 12957321
5. S Heikkinen J Auwerx CA Argmann 2007 PPAR gamma in human and mouse physiology Biochim Biophys Acta 1771 999 1013 1:CAS:528:DC%2BD2sXovFens70%3D 17475546
6. C Giaginis A Tsantili-Kakoulidou S Theocharis 2007 Peroxisome proliferators -activated receptors (PPARs) in the control of bone metabolism Fundam Clin Pharmacol 21 231 244 10.1111/j.1472-8206.2007.00486.x 1:CAS:528:DC%2BD2sXmvValsrc%3D 17521292 (Pubitemid 46800478)
7. AV Schwartz DE Sellmeyer E Vittinghoff, et al. 2006 Thiazolidinedione use and bone loss in older diabetic adults J Clin Endocrinol Metab 91 3349 3354 10.1210/jc.2005-2226 1:CAS:528:DC%2BD28Xpslajt74%3D 16608888 (Pubitemid 44402103)
8. M Suzawa I Takada J Yanagisawa, et al. 2003 Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade Nat Cell Biol 5 224 230 10.1038/ncb942 1:CAS:528:DC%2BD3sXitFKmsbk%3D 12598905 (Pubitemid 36322249)
9. G Mbalaviele Y Abu-Amer A Meng, et al. 2000 Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation J Biol Chem 275 14388 14393 10.1074/jbc.275.19.14388 1:CAS:528:DC%2BD3cXjt1CnsL0%3D 10799521 (Pubitemid 30339723)
10. H Hounoki E Sugiyama SG Mohamed, et al. 2008 Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression Bone 42 765 774 10.1016/j.bone.2007.11.016 1:CAS:528:DC%2BD1cXjs1Whu70%3D 18242157
11. O Kudo Y Fujikawa I Itonaga, et al. 2002 Proinflammatory cytokine (TNFa/IL-1a) induction of human osteoclast formation J Pathol 198 220 227 10.1002/path.1190 1:CAS:528:DC%2BD3sXivV2jsrc%3D 12237882 (Pubitemid 35243880)
12. HB Kwak HM Jin H Ha, et al. 2005 Tumor necrosis factor-α induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1) Biochem Biophys Res Commun 330 1080 1086 10.1016/j.bbrc.2005.03.085 1:CAS:528:DC%2BD2MXjtVylu7g%3D 15823554
13. EJ Rhee KW Oh WY Lee, et al. 2005 The effects of C161→T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women Am J Obstet Gynecol 192 1087 1093 10.1016/j.ajog.2004.09.033 1:CAS:528:DC%2BD2MXjtVyltLk%3D 15846185 (Pubitemid 40487783)
14. E Tsuda M Goto S Mochizuki, et al. 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 234 137 142 10.1006/bbrc.1997.6603 1:CAS:528: DyaK2sXjt1ynsLw%3D 9168977 (Pubitemid 27267548)
15. N Bucay I Sarosi CR Dunstan, et al. 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1260 1268 10.1101/gad.12.9.1260 1:CAS:528:DyaK1cXjtVejsrs%3D 9573043
16. EJ Samelson KE Broe S Demissie, et al. 2008 Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip J Clin Endocrinol Metab 93 1789 1795 10.1210/jc.2007-2492 1:CAS:528:DC%2BD1cXlvFWgsLs%3D 18303076 (Pubitemid 351656519)
17. A Stern GA Laughlin J Bergstrom, et al. 2007 The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappa B legend with bone mineral density in older adults: the Rancho Bernardo study Eur J Endocrinol 156 555 562 10.1530/EJE-06-0753 1:CAS:528:DC%2BD2sXls1ynsbw%3D 17468191 (Pubitemid 46796522)
18. A Rogers G Saleh RA Hannon, et al. 2002 Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women Clin Endocrinol Metab 87 4470 4475 10.1210/jc.2002-020396 1:CAS:528:DC%2BD38XnvFCku74%3D (Pubitemid 35247027)
19. S Khosla HM Arrighi LJ Melton 3rd, et al. 2002 Correlates of osteoprotegerin levels in women and men Osteoporos Int 13 394 399 10.1007/s001980200045 1:CAS:528:DC%2BD38XlsF2gtLo%3D 12086350 (Pubitemid 34625396)
20. S Ogawa T Urano T Hosoi, et al. 1999 Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPAR gamma expression in osteoblasts Biochem Biophys Res Commun 260 122 126 10.1006/bbrc.1999.0896 1:CAS:528:DyaK1MXjvFWru7o%3D 10381354 (Pubitemid 29351795)
21. M Iki S Kagamimori Y Kagawa, et al. 2001 Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study Osteoporos Int 12 529 537 10.1007/s001980170073 1:STN:280:DC%2BD3MvosFagug%3D%3D 11527049 (Pubitemid 32777428)
22. M Iki A Morita Y Ikeda, et al. 2006 Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study Osteoporos Int 17 1086 1095 10.1007/s00198-005-0052-3 1:CAS:528:DC%2BD28XltlOju7s%3D 16758145 (Pubitemid 43864861)
23. WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843
24. Y Sato J Tamaki F Kitayama, et al. 2005 Development of a food-frequency questionnaire to measure the dietary calcium intake of adult Japanese women Tohoku J Exp Med 207 217 222 10.1620/tjem.207.217 1:CAS:528:DC%2BD2MXhtFOht77P 16210833 (Pubitemid 41601052)
25. R Rizzoli JP Bonjour SL Ferrari 2001 Osteoporosis, genetics and hormones J Mol Endocrinol 26 79 94 10.1677/jme.0.0260079 1:CAS:528:DC%2BD3MXis1KlsrY%3D 11241160 (Pubitemid 32266184)
26. J Gajewska J Ambroszkiewicz T Laskowska-Klita 2006 Osteoprotegerin and C-peptide of type 1 collagen in Polish healthy children and adolescents Adv Med Sci 51 269 272 1:CAS:528:DC%2BD2sXitlaisLc%3D 17357324
27. KA Rouster-Stevens CB Langman HE Price, et al. 2007 RANKL: osteoprotogerin ratio and bone mineral density in children with untreated juvenile dermatomyositis Arthritis Rheum 56 977 983 10.1002/art.22433 1:CAS:528:DC%2BD2sXjs1yks70%3D 17328075 (Pubitemid 46399446)
28. LC Hofbauer S Khosla CR Dunstan, et al. 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2 12 10.1359/jbmr.2000.15.1.2 1:CAS:528:DC%2BD3cXmsVygsQ%3D%3D 10646108
29. YM Henry D Fatayerji R Eastell 2004 Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density Osteoporos Int 15 263 273 10.1007/s00198-003-1542-9 14985946 (Pubitemid 38543944)